These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38760675)

  • 1. Deciphering smooth muscle cell heterogeneity in atherosclerotic plaques and constructing model: a multi-omics approach with focus on KLF15/IGFBP4 axis.
    Peng Z; Kan Q; Wang K; Deng T; Wang S; Wu R; Yao C
    BMC Genomics; 2024 May; 25(1):490. PubMed ID: 38760675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.
    von der Thüsen JH; Borensztajn KS; Moimas S; van Heiningen S; Teeling P; van Berkel TJ; Biessen EA
    Am J Pathol; 2011 Feb; 178(2):924-34. PubMed ID: 21281823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.
    Ding Y; Zhang M; Zhang W; Lu Q; Cai Z; Song P; Okon IS; Xiao L; Zou MH
    Circ Res; 2016 Sep; 119(6):718-30. PubMed ID: 27439892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein deglycase DJ-1 deficiency induces phenotypic switching in vascular smooth muscle cells and exacerbates atherosclerotic plaque instability.
    Wang ZY; Cheng J; Liu B; Xie F; Li CL; Qiao W; Lu QH; Wang Y; Zhang MX
    J Cell Mol Med; 2021 Mar; 25(6):2816-2827. PubMed ID: 33501750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and experimental validation of KMO as a critical immune-associated mitochondrial gene in unstable atherosclerotic plaque.
    Liao FJ; Shen SL; Bao HL; Li H; Zhao QW; Chen L; Gong CW; Xiong CZ; Liu WP; Li W; Liu DN
    J Transl Med; 2024 Jul; 22(1):668. PubMed ID: 39026250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of ferroptosis inhibition-enhanced atherosclerotic plaque stability: YAP1 suppresses vascular smooth muscle cell ferroptosis through GLS1.
    Chen Y; Cui Y; Li M; Xia M; Xiang Q; Mao Y; Li H; Chen J; Zeng W; Zheng X; Peng J; Dai X; Tang Z
    FASEB J; 2024 Aug; 38(15):e23850. PubMed ID: 39091212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.
    Beneit N; Martín-Ventura JL; Rubio-Longás C; Escribano Ó; García-Gómez G; Fernández S; Sesti G; Hribal ML; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2018 Feb; 17(1):31. PubMed ID: 29463262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMAL1 modulates smooth muscle cells phenotypic switch towards fibroblast-like cells and stabilizes atherosclerotic plaques by upregulating YAP1.
    Shen Y; Xu LR; Yan D; Zhou M; Han TL; Lu C; Tang X; Lin CP; Qian RZ; Guo DQ
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166450. PubMed ID: 35598770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF13 promotes VSMCs phenotypic dedifferentiation by directly binding to the SM22α promoter.
    Yuan X; Jiang C; Xue Y; Guo F; Luo M; Guo L; Gao Y; Yuan T; Xu H; Chen H
    J Cell Physiol; 2024 May; 239(5):e31251. PubMed ID: 38634445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
    He LH; Gao JH; Yu XH; Wen FJ; Luo JJ; Qin YS; Chen MX; Zhang DW; Wang ZB; Tang CK
    Eur J Pharmacol; 2020 Oct; 884():173408. PubMed ID: 32739175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway.
    Kang CM; Li WK; Yu KW; Li XH; Huang RY; Ke PF; Jin X; Cao SW; Yuan YS; Wang H; Yan J; Chen WY; Huang XZ; Zhao JJ
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34608503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability.
    Wang J; Uryga AK; Reinhold J; Figg N; Baker L; Finigan A; Gray K; Kumar S; Clarke M; Bennett M
    Circulation; 2015 Nov; 132(20):1909-19. PubMed ID: 26416809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB.
    Fang G; Tian Y; Huang S; Zhang X; Liu Y; Li Y; Du J; Gao S
    J Biol Chem; 2024 May; 300(5):107260. PubMed ID: 38582447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell Analysis Uncovers Osteoblast Factor Growth Differentiation Factor 10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease.
    Brandt KJ; Burger F; Baptista D; Roth A; Fernandes da Silva R; Montecucco F; Mach F; Miteva K
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy.
    Qian Y; Xiong S; Li L; Sun Z; Zhang L; Yuan W; Cai H; Feng G; Wang X; Yao H; Gao Y; Guo L; Wang Z
    Cardiovasc Diabetol; 2024 Oct; 23(1):358. PubMed ID: 39395983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.
    Chen W; Yu F; Di M; Li M; Chen Y; Zhang Y; Liu X; Huang X; Zhang M
    Atherosclerosis; 2018 Oct; 277():98-107. PubMed ID: 30193190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.
    Vengrenyuk Y; Nishi H; Long X; Ouimet M; Savji N; Martinez FO; Cassella CP; Moore KJ; Ramsey SA; Miano JM; Fisher EA
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):535-46. PubMed ID: 25573853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning.
    Wang J; Kang Z; Liu Y; Li Z; Liu Y; Liu J
    Front Immunol; 2022; 13():956078. PubMed ID: 36211422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.